ZA946930B - Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them - Google Patents

Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them

Info

Publication number
ZA946930B
ZA946930B ZA946930A ZA946930A ZA946930B ZA 946930 B ZA946930 B ZA 946930B ZA 946930 A ZA946930 A ZA 946930A ZA 946930 A ZA946930 A ZA 946930A ZA 946930 B ZA946930 B ZA 946930B
Authority
ZA
South Africa
Prior art keywords
benzothiadiazine
dihydro
preparations
dioxide
derivatives
Prior art date
Application number
ZA946930A
Other languages
English (en)
Inventor
Patrick Jimonet
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA946930B publication Critical patent/ZA946930B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA946930A 1993-09-17 1994-09-08 Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them ZA946930B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311089A FR2710062B1 (fr) 1993-09-17 1993-09-17 Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.

Publications (1)

Publication Number Publication Date
ZA946930B true ZA946930B (en) 1995-04-12

Family

ID=9450965

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946930A ZA946930B (en) 1993-09-17 1994-09-08 Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them

Country Status (7)

Country Link
EP (1) EP0719262A1 (ja)
JP (1) JPH09502711A (ja)
AU (1) AU7660194A (ja)
FR (1) FR2710062B1 (ja)
IL (1) IL110940A0 (ja)
WO (1) WO1995007899A1 (ja)
ZA (1) ZA946930B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889851A (en) * 1986-11-21 1989-12-26 Fujisawa Pharmaceutical Co, Ltd. Benzothiadiazine compounds, and pharmaceutical composition comprising the same
AU3957093A (en) * 1992-04-15 1993-11-18 Rhone-Poulenc Rorer S.A. 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same

Also Published As

Publication number Publication date
WO1995007899A1 (fr) 1995-03-23
EP0719262A1 (fr) 1996-07-03
JPH09502711A (ja) 1997-03-18
FR2710062B1 (fr) 1995-12-01
FR2710062A1 (fr) 1995-03-24
IL110940A0 (en) 1994-11-28
AU7660194A (en) 1995-04-03

Similar Documents

Publication Publication Date Title
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
AU8923291A (en) L-2'-desoxyuridines and pharmaceutical compositions containing them
NZ220214A (en) 3-aminopyrazole derivatives and pharmaceutical compositions
IL114535A0 (en) Urea and thiourea derivatives of azolones their preparation and pharmaceutical compositions containing them
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
IL74865A (en) 4'-amino-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL84268A (en) Amino-cyclohexyl-hydroxyalkanoic acid peptide derivatives and pharmaceutical compositions containing them
YU121389A (en) Derivatives of benzazepine and benzothiazepine
NZ222921A (en) Peptide substituted derivatives of isoxazolidines and medicaments
HUT68220A (en) Urea derivatives containing heterocyclic ring and pharmaceutical compositions containing them
HU9402980D0 (en) 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
NZ216416A (en) Benzazepine derivatives and pharmaceutical compositions
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
ZA946930B (en) Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them
IL90825A0 (en) Aminoalkylaminocarbonyl aminodiol amino acid derivatives and pharmaceutical compositions containing them
IL87586A0 (en) 3'-demethoxyepipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
NZ221502A (en) Quinazolinediones and pyridopyrimidinedione derivatives and pharmaceutical compositions
IL105391A0 (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ229751A (en) Azacyclohexyl derivatives of rifamycin and pharmaceutical compositions
NZ214231A (en) 1,3,4-thiadiazole derivatives and pharmaceutical compositions
IL92419A0 (en) Derivatives of benzoxazimes and pharmaceutical compositions containing them
ZA893441B (en) Pharmaceutical solutions of triamterene